Need Help? Call 1­-866-­796-­7386
« back to stock screener

  GALT stock: Galectin Therapeutics Inc

Current Rating
Hold/Sell

Previous Rating

Sell
Our Strong Buys
double the S&P500!
Learn more.
Company Statistics
Price
$2.64
Market Cap
189.4M
Sector
Health Care
Div. Growth
-
P/E
-
P/B
11.33
P/S
-
Dividend %
-
P/CF
-
P/FCF
-
Op. Cash Flow
-22.6K
FCF
-0.4
Op. Margin
-
Net Margin
-
ROE
-103.50%
ROI
-
ROA
-82.60%
EPS Growth
-56.50%
Current Ratio
5.5
Debt/Equity
-
Company Price P/E Div. Yield Market Cap ($Mil) Rating
Myriad Genetics, Inc. (MYGN) $31.66 - - 2.41B Strong Buy
IntriCon Corporation (IIN) $22.94 - - 200M Strong Buy
Amneal Pharmaceuticals Inc (AMRX) $4.83 - - 1.59B Strong Buy
Recro Pharma Inc (REPH) $1.83 - - 97.6M Strong Buy
Apyx Medical Corp (APYX) $9.50 - - 365.2M Strong Buy
Find great stocks now!
Avoid risky stocks
Enter your favorite tickers and click “Get Ratings”

Disclaimer

Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.

All analysis relies on publicly available financial information. Learn More